Infant formula iron fortification of 2 vs. 8 mg/L does not increase the risk of iron deficiency or impact neurodevelopment at 12 months
Journal of Pediatric Gastroenterology and Nutrition · 2026
DOI: 10.1002/jpn3.70301 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Maria Björmsjö und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Infant Formula, Lactoferrin, Food, Fortified, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Knut and Alice Wallenberg Foundation, Umeå University and Västerbotten County Council (ALF), Oskar Foundation and the KEMPE Foundation.
Abstract (Originalsprache)
Objectives
The aim of this follow‐up was to investigate how reduced iron concentration and added bovine lactoferrin in infant formula affect neurodevelopment, iron status, and growth at 12 months of age.
Methods
Swedish healthy term formula‐fed infants ( n = 180) were randomly assigned to receive, from 6 weeks to 6 months of age, a low‐iron formula (2 mg/L) fortified with bovine lactoferrin (1.0 g/L) (Lf+, n = 72), the same formula without lactoferrin fortification (Lf−, n = 72) or a control standard formula with 8 mg/L and no lactoferrin (CF, n = 36). Breast‐fed infants were recruited as a reference ( n = 72). At 12 months of age, Bayley Scales of Infant and Toddler Development‐III (BSID‐III), iron status, and anthropometrics were assessed.
Results
There were no intervention effects on BSID‐III. Explored outcomes were unaffected by lactoferrin and the two low‐iron groups (Lf+ and Lf−) were combined. The low‐iron group had lower hepcidin (37.8 vs. 49.4 ng/mL, p = 0.027), compared to the CF group. Furthermore, they had iron status indicators more similar to the breast‐fed reference group. The prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was low with no significant differences among groups. Weight and length were unaffected by intervention, however head circumference was minimally higher in infants fed low‐iron formula compared to CF with mean difference (95% confidence interval) of 0.3 (0.0–0.6) standard‐deviation‐scores, p = 0.03.
Conclusions
Infant formula iron concentration at 2 mg/L was adequate in this population of infants with low risk of ID. Adding bovine lactoferrin did not affect the explored long‐term clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
- Department of Nutrition, University of California, Davis, California, USA.
ORCID-Profile: Staffan K Berglund
Förderung
- Knut and Alice Wallenberg Foundation
- Umeå University and Västerbotten County Council (ALF)
- Oskar Foundation and the KEMPE Foundation
Zitieren
APA
Björmsjö, M., Hernell, O., Lönnerdal, B., & Berglund, S. K. (2026). Infant formula iron fortification of 2 vs. 8 mg/L does not increase the risk of iron deficiency or impact neurodevelopment at 12 months. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70301
Vancouver
Björmsjö M, Hernell O, Lönnerdal B, Berglund SK. Infant formula iron fortification of 2 vs. 8 mg/L does not increase the risk of iron deficiency or impact neurodevelopment at 12 months. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70301
BibTeX
@article{Bjrmsj2026,
author = {Björmsjö, Maria and Hernell, Olle and Lönnerdal, Bo and Berglund, Staffan K},
title = {Infant formula iron fortification of 2 vs. 8 mg/L does not increase the risk of iron deficiency or impact neurodevelopment at 12 months},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70301}
}
EUVIMED